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A B S T R A C T
Obsessive-compulsive disorder (OCD) is a heterogenous disorder with different clinical presentations. The most com-
mon symptoms are those that involve contamination, possible harm, ordering/symmetry, aggressive/sexual/religious con-
cerns and hoarding. A variety of less common symptoms have been described. Unusual OCD symptoms may lead to
misdiagnosis, inappropriate treatmant with possible serious side effects. In this report we present a case of an adolescent
girl in which unusual OCD presentation and symptoms were misinterpreted to represent psychosis and exacerbation of
OCD symptoms with risperidone and clozapine treatmant. We discuss the possible pathophysiological mechanisms of
OCD symptom exacerbation, clinical implications, and successful management of this case, with fluvoxamine therapy.
This case may represent the first report of musical obsessions successfully managed with fluvoxamine therapy.
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Introduction
Obsessive-compulsive disorder (OCD) is a heteroge-
nous psychiatric disorder with different clinical presen-
tations. The most common symptoms are those that in-
volve contamination, possible harm, ordering/symmetry,
aggressive/sexual/religious concerns and hoarding. A va-
riety of less common symptoms have been described in-
cluding unusual somatic, sensory, stereotypic, impulsive,
interpersonal, abstract and musical symptoms1. Unusual
OCD symptoms may lead to misdiagnosis and mistreat-
mant with possible serious side effects and a great im-
pact on patient’s prognosis.
We present a case of an adolescent girl in which un-
usual OCD presentation and symptoms were misinter-
preted to represent psychosis and exacerbation of OCD
symptoms during risperidone and clozapine treatment.
We discuss the possible pathophysiological mechanisms
of OCD symptom exacerbation, clinical implications, and
successful management of this case with fluvoxamine
treatment.
Case Report
At the age of 17 the patient presented in the adult
outpatient psychiatric unit with intensive anxiety, in-
somnia, irritating thoughts running through her head,
occasional depersonalization and derealization lasting
for about a month. At the time of her first presentation
the patient reported that the disturbing thoughts inter-
fered with normal train of thought causing significant
subjective distress and impairment in her daily activities
and function. She continued to attend school, but her
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grades dropped significantly. The patient did not reveal
the content of the thoughts at that time. There was no
past, personal or family history of significance. She was
diagnosed with acute psychosis by a general psychiatrist.
Olanzapine treatment was started and titrated up to 20
mg/day, but discontinued after 6 weeks because of a
weight gain of more than six kilograms and no improve-
ment in the clinical picture. Risperidone was initiated
and at the dosage of 6 mg/day six weeks later the patient
reported frightening aggressive thoughts and sexual im-
ages. These symptoms were interpreted as psychotic fea-
tures resistant to risperidone. Risperidone was with-
drawn and haloperidole was administered. After 6 weeks
of haloperidole treatment at the dose od 4 mg/day, the
disturbing thoughts persisted, although their severity
was attenuated. Because her symptoms were considered
as resistant to both atypical and classical antipsychotics,
it was decided to switch to clozapine treatment. After 6
weeks with 150 mg/day dosage of clozapine the patient
started to complain of irritating sounds and music. Again,
the patient did not explain this symptom in details and
songs were concluded to be auditory hallucinations. Four
weeks later, with clozapine dosage increased to 200 mg/day
and augmentation with flufenazine 5 mg/day, her sym-
poms had increased to the worst that had ever been. Feel-
ings of derealization and depersonalization appeared of-
ten. The dosage of clozapine and flufenazine was gradu-
ally reduced and ziprasidone was started.
Clinical presentation and nonresponse to antipsycho-
tics called upon the need for diagnostic reevaluation. The
patient was referred to our child and adolescent psychi-
atric hospital. Her chief complaint was the recurrent and
persistent musical tunes accompanied by severe anxiety
and depersonalization. The music included popular songs
and commercial jingles. At the time of her first presenta-
tion, the music appeared occasionally, but severily in-
creasing with clozapine therapy causing significant sub-
jective distress. She had full insight into the senseless-
ness and excessiveness of the music, and recognized that
the musical tunes were a product of her own mind and
not imposed from outside. She also experienced unwan-
ted aggressive thoughts to kill her mother and disgusting
sexual images which overwhelmed her with shame and
guilt. Her attempts to control unpleasant obsessions by
occupying her mind with other thoughts were unsuccess-
ful and anxiety overwhelmed her. There was no evidence
of overt compulsive behavior, delusion, perceptual disor-
der, depressive ideations or cognitive impairment. Physi-
cal examination and the routine blood investigation were
within normal limits. The EEG examination was within
normal limits excluding the possibility of temporal lobe
epilepsy. The magnetic resonance imaging of the brain
was normal.
According to DSM-IV the patient fulfilled criteria for
OCD. At the time of her reassessment, obsessions con-
sumed about 8 hours/day with a total score of 25 on the
Children’s Yale-Brown Obsessive Compulsive Scale (CY-
BOCS)2. At that time, the patient was taking ziprasidone
(160 mg/day), flufenazine (2.5 mg/day) and clozapine (75
mg/day). After gradual discontinuation of antipsychotic
therapy over one month, obsessive symptoms persisted
although their severity was reduced with (CYBOCS sco-
re=20). Fluvoxamine was prescribed and after two mon-
ths of fluvoxamine treatment at the dose of 200 mg/day,
aggressive and musical obsessions had disappeared com-
pletely. Over the next month at the dose of fluvoxamine
of 300 mg/day, sexual obsessions were markedly decrea-
sed to a subclinical level (CYBOCS score=7). The patient
continued to improve over the next three months and her
OCD had remitted completely (CYBOCS score=0). The
improvement persisted in the following 6 months’ fol-
low-up with fluvoxamine at the dose of 300 mg/day.
Discussion
Unusual presentation of OCD is not uncommon. One
of the reasons for unusual presentation of OCD leading
to difficulties in diagnosing is a secrecy associated with
this condition. Although patients with OCD generally
have full insight into the excessiveness of their symp-
toms, many patients are ashamed and confused by their
symptoms, fear they are losing control and going mad,
and actively hide their symptoms. They may present only
with severe anxiety and feelings of depersonalization and
derealization. Another reason for unusual presentation
of OCD may be the presence of a pure obsessional disor-
der. About 5% of the patients have obsessive thoughts
with few or no compulsions present3. In such patients
with pure obsessional disorder, obsessions are often char-
acterized as somatic, aggressive, religious, or sexual4.
OCD patients with obsessions related to music have been
proposed to constitute a further group of pure obsessive
disorder5. Our patient was primarily displaying aggres-
sive, sexual and musical obsessions. According to the Lee
and Kwon’s model6 sexual and aggressive obsessions be-
long to the autogenous subtype of obsessions which tend
to be perceived as very ego-dystonic and are highly asso-
ciated with with cognitive/covert symptoms of OCD (e.g.,
mental compulsions such as tought stopping, distraction)
which was present in our patient. Thus, as presented in
our case, the secrecy and absence of behavioral symp-
toms may lead to poor recognition by health profession-
als, misdiagnosis and mistreatment of OCD.
Several cases of musical symptoms in idiopathic or
aquired OCD have been reported5,7-10 with some of them
representing diagnostic dilemmas and initially misdiag-
nosed for schizophrenia. The musical symptoms in our
patient were experienced as a product of her own mind,
intrusive and senseless causing marked anxiety, distress
and impairment of social and academic functioning ac-
companied by an attempt to get rid of them. Thus, the
musical symptoms of the present case are consistent
with the psychopathological characteristics of obsessions
defined in the DSM-IV. In the present case, the clinical
presentation of the sounds and musical tunes appears to
be phenomenologically distinct from musical hallucina-
tions because hallucinations are not experienced as ego-
-dystonic, nor is there an attempt to suppress or to neu-
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tralize them with other thoughts. Moreover, a robust
evidence to biologically support a diagnosis of OCD in
our case is a treatment response to serotonin selective
re-uptake inhibitor fluvoxamine but not antipsychotics.
In our patient musical obsessions were present along
with aggressive and sexual obsessions and were most
likely aggravated by clozapine, but responded to the
therapy of fluvoxamine. To our knowledge, no other re-
ported case of musical obsessions responding to selective
serotonin reuptake inhibitors (SSRIs) monotherapy, flu-
voxamine in particular, has been found. This is in con-
trast with the report of ineffectiveness of SSRIs for musi-
cal obsessions8. However, some previous reports have
documented a significant response of musical obsessions
to an adequate trial of clomipramine5,9 or a combination
of fluvoxamine and clomipramine10.
Evidence indicates that atypical antipsychotics may
aggravate pre-existing and induce de novo obsessive-
-compulsive symptoms (OCS) or OCD in patients with
schizophrenia and other primary diagnoses that included
a psychotic element11 but also OCD12. This may be the
case in our patient with aggressive and sexual obsessions
aggravated by risperidone, and musical obsessions most
likely exacerbated by clozapine. The natural fluctuations
in the course of OCD may have also caused our patient’s
increased symptoms, but the quantitative intensity of
the change and temporal relation to risperidone and
clozapine makes this unlikely. In this patient, the sever-
ity of OCS was affected by risperidone and clozapine in a
dose dependent fashion, which is consistent with previ-
ous reports of risperidone-induced OCS above the dosage
of 3 mg/day13,14 and clozapine-induced OCS above the
dosage of 150 mg/day15,16. Risperidone aggravated OCS
after 6 weeks of treatment in our case, while clozapine
exacerbated OCS after two months. This is also consis-
tent with previous reports of the latency of appearance of
OCSs related to the beginning of atypical antipsychotic
treatment ranging from days to weeks for risperido-
ne13,17, and 2 months to 1 year for clozapine18. It is possi-
ble that aggressive and sexual obsessions in the present
case might have been exacerbated with clozapine at
higher doses or longer duration of treatment. Although
disinhibition of dopamine through 5HT2A and 5HT2C
receptor antagonism has been suggested to be responsi-
ble for the emergence of OCSs with atypical antipsycho-
tic treatment18,19, for clozapine another possible mecha-
nism, a super-sensitivity in 5-HT receptors as a result of
the potent 5-HT antagonistic activity, may also play a
role20.
Reports of exacerbation of OCD symptoms with the
use of atypical antipsychotics are limited to individuals
with a primary psychotic disorder. There is only one re-
port of risperidone worsening fluoxetine-treated OCD12.
On the other hand, atypical antipsychotics have been
used as treatment adjuncts in primary OCD refractory to
serotonin reuptake inhibitors (SRIs) with no report of
worsening of OCS21. As our case shows, atypical antipsy-
chotics may have paradoxical effect and exacerbate OCD
symptoms when administered without SSRIs. Atypical
antipsychotics initially reduce the level of anxiety in
OCD patients, but severely increase it with worsening of
primary OCD symptoms over time when administered as
monotherapy. Moreover, given the different subtypes of
OCD most likely representing neurobiologically distinct
subgroups of patients, there may be a subset of pure
OCD patients particularly vulnerable to worsening of
their OCD symptoms with atypical antipsychotics.
Conclusion
This case illustrates the complex issue of diagnosing
»pure obsessive disorder» and the risk of misdiagnosis
and mistreatment of OCD when the presenting symp-
toms are unusual. Increased awareness of professionals
involved in treating OCD patients of a wide range od
OCD symptoms is important to maximize appropriate di-
agnosis and early intervention of this common psychiat-
ric condition. Treatment of OCD with atiypical anti-
psychotics may exert a biphasic effect on OCD symptoms
and exacerbate OCD symptoms when administered with-
out SSRIs. Further research on OCD symptom dimen-
sions and more unusual OCD symptoms, may ultimately
shed additional light on the psychobiology of OCD and fa-
cilitate refinement of the existing and development of
new treatments.
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POGRE[NA DIJAGNOZA I POGOR[ANJE NEOBI^NE PREZENTACIJE
OPSESIVNO-KOMPULZIVNOG POREME]AJA S RISPERIDONOM I KLOZAPINOM
KOD ADOLESCENTICE: PRIKAZ SLU^AJA
S A @ E T A K
Opsesivno-kompulzivni poreme}aj (OKP) je heterogeni poreme}aj s razli~itim klini~kim manifestacijama. Naj~e{}i
simptomi su oni koji uklju~uju strah od zaraze, mogu}e {tete, simetriju/spremanje, agresivne/seksualne/religiozne brige
te sakupljanje. Opisani su i razli~iti manje u~estali simptomi. Rijetki simptomi OKP mogu rezultirati pogre{nom dijag-
nozom, neadekvatnim lije~enjem s mogu}im ozbiljnim nuspojavama. U ovim prikazu iznosimo slu~aj adolescentice kod
koje su neobi~na prezentacija OKP i simptomi doveli do pogre{ne dijagnoze psihoze, pogor{anja simptomatologije OKP
tijekom terapije risperidonom i klozapinom. U ~lanku se raspravlja o mogu}im patofiziolo{kim mehanizmima pogor-
{anja OKP s terapijom risperidonom i klozapinom, klini~kim implikacijama i uspje{nim lije~enjem ovog slu~aja s tera-
pijom fluvoksaminom. Ovaj slu~aj mo`e predstavljati prvi slu~aj uspje{nog lije~enja muzi~kih opsesija s terapijom flu-
voksaminom.
V. Bori~evi} Mar{ani} et al.: Unusual OCD Presentation, Coll. Antropol. 35 (2011) Suppl. 1: 293–296
296
